药品首页 >
产品预订 > 稀缺预定
全球品牌 > 诺华/Novartis

Xromi 羟基脲口服液

通用名称羟基脲口服液 hydroxycarbamide
品牌名称Xromi
产地|公司爱尔兰(Ireland) | 诺华(Novartis)
技术状态
成分|含量100mg/ml, 100ml
包装|存储1瓶/盒 室温
微信客服
Xirou_Canada
微信ID
(8:00-15:00)
服务时间
通用中文 羟基脲口服液 通用外文 hydroxycarbamide
品牌中文 品牌外文 Xromi
其他名称 羟基脲
公司 诺华(Novartis) 产地 爱尔兰(Ireland)
含量 100mg/ml, 100ml 包装 1瓶/盒
剂型给药 口服液体 储存 室温
适用范围 预防2岁以上患者的镰状细胞病的血管闭塞性并发症
通用中文 羟基脲口服液
通用外文 hydroxycarbamide
品牌中文
品牌外文 Xromi
其他名称 羟基脲
公司 诺华(Novartis)
产地 爱尔兰(Ireland)
含量 100mg/ml, 100ml
包装 1瓶/盒
剂型给药 口服液体
储存 室温
适用范围 预防2岁以上患者的镰状细胞病的血管闭塞性并发症

使用说明书

(免责声明:本说明书仅供参考,不作为治疗的依据,不可取代任何医生、药剂师等专业性的指导。本站不提供治疗建议,药物是否适合您,请专业医生(或药剂师)决定。)
等待内容更新

中文说明

(免责声明:本说明书仅供参考,不作为治疗的依据,不可取代任何医生、药剂师等专业性的指导。本站不提供治疗建议,药物是否适合您,请专业医生(或药剂师)决定。)

2019年4月26日,人用药品委员会(CHMP)采纳了积极意见,建议批准药品Xromi的上市许可,旨在预防患者的镰状细胞病血管闭塞并发症。 2岁。该药品的申请人是Nova Laboratories Ireland Limited。

 

Xromi将以100 mg / ml口服溶液的形式提供。 Xromi的活性物质是羟基脲,一种核糖核苷酸还原酶抑制剂(ATC代码:L01XX05),其通过干扰DNA的合成起作用,而不干扰核糖核酸或蛋白质的合成。

 

Xromi的好处是能够减少镰状细胞病的血管闭塞并发症。最常见的副作用是骨髓抑制,包括中性粒细胞减少症,网状细胞减少症,大红细胞增多症,血小板减少症,贫血症,头痛,头晕,恶心,便秘,皮肤溃疡,口腔,指甲和皮肤色素沉着,皮肤干燥和脱发。

 

Xromi是Hydrea的混合药物1,自1986年5月29日起在欧盟获得批准.Xromi含有与Hydrea相同的活性物质,但获得了不同的适应症。 Hydrea被授权治疗某些癌症。

 

完整的适应症是:“预防2岁以上患者的镰状细胞病的血管闭塞性并发症。”建议Xromi由医生或其他有镰状细胞病患者管理经验的医疗专业人员开处方。

 

有关使用本产品的详细建议将在产品特性摘要(SmPC)中进行描述,该摘要将在欧洲公共评估报告(EPAR)中公布,并在获得上市许可后以所有欧盟官方语言提供。由欧洲委员会。

 

 

 

 

 

外文说明

(免责声明:本说明书仅供参考,不作为治疗的依据,不可取代任何医生、药剂师等专业性的指导。本站不提供治疗建议,药物是否适合您,请专业医生(或药剂师)决定。)


 

Xromi® (Hydroxycarbamide)

 

100 mg/ml oral solution

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Patient / Parent Guide

 

Important safety information about serious side effects that you need to be aware of before, during and after treatment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

XromUK001 September 2019 (Patient/Parent Guide)


Contents

 

 

 

 

 

 

 

 

 

 

 

 

Page.

1.

Why your doctor has prescribed Hydroxycarbamide

3.

 

 

 

2.

Hydroxycarbamide must be handled with care

4.

 

- Handling

 

 

 

 

3.

When you are treated with Hydroxycarbamide it is very important to be regularly monitored

8.

 

by your doctor

 

 

3.1Reduced production of blood cells in the bone marrow (the soft, organic, sponge like material in the cavities of bones)

 

- Other medicines that reduce the production of blood cells in the bone marrow and radiotherapy treatment

 

3.2Use with medicines that inhibit or destroy a retrovirus such as HIV

 

3.3Ulcers of the skin and inflammation of blood vessels

 

3.4Long term safety

 

- Hydroxycarbamide may affect the DNA synthesis. Development of cancer such as skin cancer and secondary cancers e.g. secondary leukaemia in elderly patients

3.5Use of hydroxycarbamide if you have liver and/or kidney disease

 

3.6Effect of hydroxycarbamide on the development of the foetus (birth defects); male fertility; need for contraception; breastfeeding

 

(i) If you are a man

 

(ii) If you are a woman of childbearing potential

 

3.7Influence on the growth of the children and adolescents

 

 

4.  Side effects which have been observed with Hydroxycarbamide

12.

-Key signs and symptoms of serious adverse reactions

 

 

 

5.  Important signs and symptoms of the disease

13.

 

- Acute painful crises

 

- When to seek urgent attention from healthcare provider

 

- Infections

 

 

6.  Patient information leaflet

15.

 

 

 

 

 

 

 

 

2 XromUK001 September 2019 (Patient/Parent Guide)


1. Why your doctor has prescribed Hydroxycarbamide

 

 

 

Your doctor has prescribed Hydroxycarbamide for you or your child to treat

 

a condition called sickle cell disease. This is an inherited disease that affects the red cells of the blood. Some cells become abnormal, rigid and take a crescent or sickle shape which leads to anaemia. The sickle cells also get stuck in blood vessels, blocking blood flow. This can cause acute pain crises and organ damage

 

Hydroxycarbamide is used to prevent the complications of blocked blood vessels caused by sickle cell disease in patients over 2 years of age

 

 

Hydroxycarbamide will decrease the number of painful crises as well as the need for hospitalisation as a result of the disease

 

Hydroxycarbamide has been prescribed for you. Never give it to someone else, even if he or she has the same disorder for which you are being treated

 

 

Take this medication exactly as it has been prescribed for you by your doctor.

 

 

Take your treatment regularly and do not change the dose yourself

 

 

 

Hydroxycarbamide may interact with other medicines and live virus vaccines. Please tell your doctor if you are taking or have recently taken any other medicines, even those obtained without a prescription. Please tell your doctor if you have had or are due to have any vaccfrom clipboardsles, mumps, rubella (MMR), chicken pox)

 

 

 

 

 

Before starting the treatment, read the package leaflet present

 

in each box of Hydroxycarbamide

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3 XromUK001 September 2019 (Patient/Parent Guide)


2. Hydroxycarbamide must be handled with care

 

 

Please use the syringe as advised by your doctor or pharmacist

 

Ask your doctor or pharmacist if you have any questions

 

 

 

 

Each pack contains one bottle 150 ml capped with a child-resistant closure, a bottle adaptor and two dosing syringes (a red syringe graduated to 3 ml and a white syringe graduated to 12 ml)

 

 

 

 

Packaging

 

Contents

 

 

 

Bottle

 

 

 

 

12 ml syringe(white)

 

(for doses more than 3 ml)

 

 

 

 

 

Bottle adaptor

3 ml syringe(red)

 

(for doses less than

 

or equal to 3 ml)

 

 

 

 

 

 

 

Syringe Type

 

 

 

 

Syringe volume

3 ml

 

12 ml

 

 

 

 

Colour

Red

 

White

 

 

 

 

Measurements

0.5 ml to 3 ml

 

1 ml to 12 ml

 

 

 

 

 

 

 

Your doctor or pharmacist will advise which syringe to use depending on the dose that has been prescribed

 

 

 

 

 

4 XromUK001 September 2019 (Patient/Parent Guide)


IMPORTANT

 

Women who are pregnant, planning to be or breastfeeding should not handle Hydroxycarbamide

 

Hydroxycarbamide may be taken with or after meals at any time of the day.However, the choice of method and time of day should be consistent from day to day

 

Water should be taken after each dose of Hydroxycarbamide, to assist accurate and consistent dose delivery to the stomach

 

 

 

Keep out of the sight and reach of children. Accidental ingestion can be lethal for children

 

 

Store in a refrigerator (2°C - 8°C). After first opening of the bottle, discard any unused contents after 12 weeks

 

 

Keep the bottle tightly closed to prevent spoilage of the medicine and reduce the risk of accidental spillage. To minimise air bubbles, the bottle shouldnot be shaken prior to dosing

5 XromUK001 September 2019 (Patient/Parent Guide)


Handling

from clipboardfrom clipboardfrom clipboard 

 

1. Wash your hands before and after administering a dose. Wipe up spillages immediately

from clipboard 

 

4. Push the adaptor firmly into the top of the bottle and leave in place for future doses


2. Put on disposable hand gloves to decrease the risk of exposure

from clipboard 

 


5. Push the tip of the dosing syringe into the hole in the adaptor. Your doctor or pharmacist will advise you of the correct syringe to use, either the 3 ml (red syringe) or the 12 ml (white syringe) in order to give the correct dose


3. Remove the bottle

 

6. Turn the bottle upside down. Pull the plunger of the syringe back so that the medicine is drawn from the bottle into the syringe. Pull the plunger back to the point on the scale that corresponds to the dose prescribed


 

If you are not sure about how much medicine to draw into the syringe,

 

always ask your doctor or nurse for advice

from clipboardfrom clipboardfrom clipboard 


 

 

 

 

 

 

 

 

 

 

 

 

7. Turn the bottle back the right way up and carefully remove the syringe from the adaptor, holding it by the barrel rather than the plunger


 

 

 

 

 

 

 

 

 

 

 

8. Gently put the tip of the syringe into your mouth and to the inside of your cheek


 

 

 

 

 

 

 

 

 

 

 

9. Slowly and gently push the plunger down to gently squirt the medicine into the inside of your cheek and swallow it. DO NOT forcefully push down the plunger, or squirt the medicine to the back of your mouth or throat, as you may choke


 

 

6 XromUK001 September 2019 (Patient/Parent Guide)


from clipboard 

 

 

 

 

 

 

 

 

 

10. Remove the syringe from your mouth

from clipboard 


 

 

 

 

 

 

 

 

 

11. Swallow the dose of oral solution then drink some water, making sure no medicine

is left in your mouth

from clipboard 


 

 

 

 

 

 

 

 

 

12. Put the cap back on the bottle with the adaptor left in place. Ensure that the cap is tightly closed

from clipboardfrom clipboard 


 

 

 

 

 

 

 

 

 

 

 

 

 

13. Wash the syringes with cold or warm tap water and rinse well. Hold the syringe under water and move the plunger up and down several times to make sure the inside of the syringe is clean. Let the syringe dry completely before you use it again

 


 

 

 

 

 

 

 

 

 

 

 

 

14. Store the syringe in a hygienic place with the medicine


 

 

 

Wash immediately and thoroughly with soap and water if Hydroxycarbamide

 

comes into contact with skin, eyes or nose

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7 XromUK001 September 2019 (Patient/Parent Guide)


3. When you are treated with Hydroxycarbamide, it is very important to be regularly monitored by your doctor

 

 

 

3.1 Reduced production of blood cells in the bone marrow (the soft, organic, sponge like material in the cavities of bones)

 

When you take Hydroxycarbamide your doctor will need to take regular blood tests, to check the number and type of cells in your blood

 

These tests may be performed

 

Initially every two weeks and then every 2-3 months

 

 

Depending on these results your doctor may change your dose or temporarily withhold the dosing

 

 

- Other medicines that reduce the production of blood cells in the bone marrow and radiotherapy treatment

 

You will have to talk to your doctor, pharmacist or nurse before taking Hydroxycarbamide

 

If you are taking other myelosuppressive medicines (medicines that decrease production of red, white, or coagulating blood cells)

 

If you are receiving radiation therapy, chemotherapy, or are currently taking any medicines for cancer treatment (especially interferon therapy)

 

 

When used with Hydroxycarbamide

 

There is greater chance of bone marrow depression, gastro-intestinal disturbances and soreness and inflammation of the mouth and gut

 

 

Redness of the skin may reoccur when Hydroxycarbamide is given to patients who have received irradiation therapy in the past

 

3.2 Use with medicines that inhibit or destroy a retrovirus such as HIV

 

Tell your doctor, nurse or pharmacist if you are taking any antiretroviral medicines (those that inhibit or destroy a retrovirus such as HIV), e.g. didanosine, stavudine and indinavir

 

Hydroxycarbamide should not be used in combination with antiretroviral agents for HIV diseaseA drop in your white cell count, severe liver damage and failure and peripheral neuropathy may occur

 

 

 

8 XromUK001 September 2019 (Patient/Parent Guide)


3.3 Ulcers of the skin and inflammation of blood vessels

 

 

 

Ulcers

 

 

Talk to your doctor, pharmacist or nurse before taking Hydroxycarbamide if you have leg ulcers or wounds

 

Leg ulcers are a common complication of sickle cell disease, but have also been reported in patients treated with hydroxycarbamide. In patients with leg ulcers, hydroxycarbamide should be used with caution

 

Talk to your doctor if you develop inflammation or ulceration of the mouth (oral mucositis) when treated with Hydroxycarbamide

 

 

Inflammation of the blood vessels (vasculitis)

 

 

During therapy with hydroxycarbamide, vasculitis in the skin (which can sometimes lead to ulcers and gangrene) has occurred in patients with myeloproliferative disorders

 

The risk is increased in patients who have previously received or are receiving interferon therapy

 

Hydroxycarbamide should be discontinued if skin ulcers develop

 

 

3.4 Long term safety

 

- Hydroxycarbamide may affect the DNA synthesis.

Development of cancer such as skin cancer and secondary cancers e.g. secondary leukaemia in elderly patients

 

Hydroxycarbamide may potentially affect DNA synthesis causing damage to the cells In patients receiving long-term hydroxycarbamide there have been reports of

 

Skin cancer

 

 

Please protect your skin from sun exposure, conduct self-inspection of the skin and be screened for secondary malignancies during your routine follow-up visits to the doctor (especially if you are older)

 

Isolated cases of cancer of blood cells (leukaemia)

 

 

In some patients receiving long-term therapy with hydroxycarbamide for various types of blood tumours, secondary leukaemia has been reported

 

It is unknown whether this is due to hydroxycarbamide or is a consequence of the patient’s underlying disease

 

 

 

 

 

 

 

 

 

 

9 XromUK001 September 2019 (Patient/Parent Guide)


3.5 Use of hydroxycarbamide if you have liver and/or kidney disease

 

Please talk to your doctor pharmacist or nurse if you have any liver or kidney disease

 

 

If you have kidney disease your doctor may need to give you a lower dose Hydroxycarbamide should be used with caution in patients with marked kidney disease

 

Do not take Hydroxycarbamide if you suffer from severe liver disease or/and severe kidney disease

 

 

Your kidney and liver function should be checked prior to, and repeatedly during treatment with hydroxycarbamide

 

 

Discontinue Hydroxycarbamide immediately if jaundice becomes apparent

 

 

 

3.6 Effect of hydroxycarbamide on the development of the foetus (birth defects); male fertility; need for contraception; breastfeeding

 

Talk to your doctor, nurse or pharmacist concerning the use of contraceptive measures before and during treatment with Hydroxycarbamide

 

Hydroxycarbamide is an active substance which may cause changes to the DNA (mutagenic) 


The use of effective contraception before and during treatment is strongly

 

recommended for both male and female patients

 

 

 

 

 

(i) If you are a man

 

Hydroxycarbamide may decrease your ability to father children (fertility) while you are treated

 

It is important for you to know that Hydroxycarbamide may decrease sperm production and harm your sperm

 

Absence or low amount of sperm in the semen (azoospermia or oligospermia) is a very common side effect of hydroxycarbamide. These disorders can be also associated with

 

the underlying disease. Although in general reversible, it has to be taken into account when fatherhood is desired

 

Talk to your doctor or nurse if this is a concern for you. Your doctor can inform you about the possibility of sperm conservation (cryopreservation) before the start of therapy

 

 

 

 

 

 

 

 

 

 

10 XromUK001 September 2019 (Patient/Parent Guide)


(ii) If you are a woman of childbearing potential

 

Do not take Hydroxycarbamide if you are planning to have a baby without first speaking to your doctor for advice

 

Hydroxycarbamide should be stopped 3 to 6 months prior to becoming pregnant, if possible

 

Hydroxycarbamide can potentially cause foetal harm (birth defects) when administered to a pregnant woman, as it can cross the placental barrier

 

It may affect the DNA synthesis and as it is toxic to the cells (cytotoxic) it can potentially produce birth defects (teratogenic effect)

 

Hydroxycarbamide must not be used during pregnancy

 

If you become pregnant while you are still taking Hydroxycarbamide, please contact your doctor immediately

 

Please contact your doctorimmediately if you think you may be pregnant

 

 

Breastfeeding

 

Hydroxycarbamide is excreted in human breast milk. You should not breastfeed during the treatment

 

You should not handle Hydroxycarbamide if you are pregnant, planning to be or breastfeeding

 

3.7 Influence on the growth of the children and adolescents

 

The doctor will monitor growth (height and weight) in children and adolescents, as it can be affected in patients with sickle cell disease. Currently, it is not known whether Hydroxycarbamide can impact children’s growth

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11 XromUK001 September 2019 (Patient/Parent Guide)


4. Side effects which have

 

been observed with Hydroxycarbamide

 

 

 

 

Like all medicines, Hydroxycarbamide can cause side effects (although not everybody gets them). If any of these side effects become serious, or if you notice any side effects not listed here, please tell your doctor or pharmacist

 

- Key signs and symptoms of serious adverse reactions

 

If you get any of the following side effects, talk to your doctor or go to hospital immediately

 

A severe infection

 

 

Fever or chills

 

 

Tiredness and/or looking pale

 

 

Unexplained bruising (accumulation of blood under the skin) or bleeding Any yellowing of the whites of the eyes or skin (jaundice)

 

Inflammation of the skin causing red scaly patches and possibly occurring together with pain in the joints

 

 

Ulcers or wounds on legs

 

 

Sore (open skin infection) on your skin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12 XromUK001 September 2019 (Patient/Parent Guide)


5. Important signs and symptoms of the disease

 

 

 

Some signs and symptoms may require you to call a doctor or to visit an emergency department

 

These may be caused by disease progression or show that your treatment is not working or be a side effect linked to the medicinal product

 

You should never hesitate to discuss your condition, or your treatment with any doctor, especially if it is not your usual doctor. This will help the doctor to choose the right treatment and to administer it more rapidly

 

- Acute painful crises

 

This is referred to as an episode of extreme pain, and is the major symptom of the sickle cell disease which can start in childhood or adulthood

 

The pain which affects mainly the bones and joints, is often difficult to relieve by usual painkillers (analgesics). Other organs may be affected (lungs, kidneys, brain, inner ear, etc.), which explains why the symptoms vary greatly between patients. The crises may occur suddenly and resolve rapidly or last several days. The episodes of acute pain may occur several times a year. For severe painful crises, most patients require hospitalisation

 

- When to seek urgent attention from healthcare provider

 

Seek urgent attention from a healthcare provider in the following cases

 

 

Pain which is not relieved by usual painkillers (analgesics)

 

 

Your temperature is above 38.5°C, even if there is no pain

 

 

Vomiting

 

 

A sudden pallor, fatigue or impairment of your health status, a sudden increase of the volume of your spleen (your doctor will tell you how to palpate your spleen)

 

If you are a man and you have an involuntary, painful erection which lasts for more than three hours (priapism)

 

 

When the vaso-occlusive crises affect the lungs, it is called “acute chest syndrome” (ACS):

 

The patient has chest pains, fever and difficult breathing. He/she is out of breath.

 

This can occur in both adults and children. If it does, a doctor must be seenurgently

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13 XromUK001 September 2019 (Patient/Parent Guide)


- Infections

 

When you have sickle cell disease, you are more susceptible to infections (illness with fever). This is mainly because your spleen is less effective at filtering out certain types of bacteria. Any infection can trigger a vaso- occlusive crisis or an acute chest syndrome. It is therefore important for you to consult your doctor if you have a fever or any other sign or symptom of infection

 

 

 

 

 

Reporting of side effects

 

If you get any side effects, talk to your doctor, pharmacist or nurse.

 

This includes any possible side effects not listed in this leaflet.

 

You can also report side effects directly via the Yellow Card Scheme

 

Website: www.mhra.gov.uk/yellowcard or search forMHRA Yellow Card in the Google Play or Apple App Store

 

By reporting side effects you can help provide more information on the safety of this medicine

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14 XromUK001 September 2019 (Patient/Parent Guide)


6. Patient Information Leaflet

 

 

 

 

 

 

 

 

The patient information leaflet (PIL) is available on the Electronic Medicines Compendium (www.medicines.org.uk) athttps://www.medicines.org.uk/emc/product/10549/pil

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15 XromUK001 September 2019 (Patient/Parent Guide)